Kusumi Eiji, Kami Masahiro, Hara Shigeo, Hoshino Junichi, Yamaguchi Yutaka, Murashige Naoko, Kishi Yukiko, Shibagaki Yugo, Shibata Taro, Matsumura Tomoko, Yuji Koichiro, Masuoka Kazuhiro, Wake Atsushi, Miyakoshi Shigesaburo, Taniguchi Shuichi
Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Division of Exploratory Research, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 1088639, Japan.
Int J Hematol. 2008 Mar;87(2):225-230. doi: 10.1007/s12185-008-0026-2. Epub 2008 Feb 9.
To investigate the association between graft-versus-host disease (GVHD) and renal injury after allogeneic stem cell transplantation (allo-SCT), we compared autopsy findings of 26 consecutive allo-SCT recipients with two control groups: patients with hematologic malignancies who received cytotoxic chemotherapy alone (Control 1, n = 21) and those with non-hematologic diseases (Control 2, n = 12). We evaluated the following renal pathology; renal tubulitis, allograft glomerulitis, intimal arteritis, allograft nephropathy, and peritubular capillaritis. These changes were found in 11 allo-SCT recipients and 10 patients in Control 1, but none in Control 2. While overall frequency of renal impairments was similar between allo-SCT recipients and Control 1 (3/26 vs. 1/21), allo-SCT recipients were more likely to have renal tubulitis and peritubular capillaritis compared to Control 1 (5/26 vs. 1/21), but less likely to present with glomerulitis (1/26 vs. 6/21). Grade III-IV acute or extensive-type chronic GVHD were seen in all of the three patients with renal tubulitis and four of the five patients with peritubular capillaritis. Allo-SCT recipients with severe GVHD tended to have tubulitis and peritubular capillaritis. These findings have implications of some renal impairment attributable to GVHD.
为了研究异基因干细胞移植(allo-SCT)后移植物抗宿主病(GVHD)与肾损伤之间的关联,我们将26例连续的allo-SCT受者的尸检结果与两个对照组进行了比较:仅接受细胞毒性化疗的血液系统恶性肿瘤患者(对照组1,n = 21)和患有非血液系统疾病的患者(对照组2,n = 12)。我们评估了以下肾脏病理情况:肾小管炎、移植肾肾小球炎、内膜动脉炎、移植肾病和肾小管周围毛细血管炎。这些改变在11例allo-SCT受者和对照组1的10例患者中发现,但对照组2中未发现。虽然allo-SCT受者和对照组1的肾功能损害总体发生率相似(3/26 vs. 1/21),但与对照组1相比,allo-SCT受者更易发生肾小管炎和肾小管周围毛细血管炎(5/26 vs. 1/21),而发生肾小球炎的可能性较小(1/26 vs. 6/21)。在所有3例患有肾小管炎的患者和5例患有肾小管周围毛细血管炎的患者中的4例中,可见III-IV级急性或广泛型慢性GVHD。患有严重GVHD的allo-SCT受者往往有肾小管炎和肾小管周围毛细血管炎。这些发现提示某些肾损伤可归因于GVHD。